Aerpio Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ARPO and buy or sell other stocks, ETFs, and their options commission-free!About ARPO
Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes.
CEODavid Lennon, PhD
CEODavid Lennon, PhD
Employees40
Employees40
HeadquartersMorristown, New Jersey
HeadquartersMorristown, New Jersey
Founded2007
Founded2007
Employees40
Employees40
ARPO Key Statistics
Market cap83.42M
Market cap83.42M
Price-Earnings ratio18.34
Price-Earnings ratio18.34
Dividend yield—
Dividend yield—
Average volume211.40K
Average volume211.40K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.81
52 Week high$3.81
52 Week low$1.39
52 Week low$1.39
Stock Snapshot
Aerpio Pharmaceuticals(ARPO) stock is priced at $1.77, giving the company a market capitalization of 83.42M. It carries a P/E multiple of 18.34.
On 2025-12-07, Aerpio Pharmaceuticals(ARPO) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 211.4K.
Over the past 52 weeks, Aerpio Pharmaceuticals(ARPO) stock has traded between a high of $3.81 and a low of $1.39.
Over the past 52 weeks, Aerpio Pharmaceuticals(ARPO) stock has traded between a high of $3.81 and a low of $1.39.
People also own
Based on the portfolios of people who own ARPO. This list is generated using Robinhood data, and it’s not a recommendation.